🇩🇪Germany

ePA-Dokumentationspflicht & Datenschutzverstöße durch manuelle Verarbeitung

1 verified sources

Definition

ePA rollout (Jan 2025) mandates that pharmacies accept digital patient records and document prescription releases. Pharmacies without automated ePA integration must manually log access requests, verify patient consent, and maintain GDPR-compliant evidence. A typical audit finds 5–15% of prescriptions lack proper ePA audit trails. Maximum DSGVO fine: €20M or 6% global revenue. Typical pharmaceutical retail margin: 25–30%, so a €2M revenue pharmacy faces €120,000–€600,000 fine exposure.

Key Findings

  • Financial Impact: DSGVO penalty range: €5,000–€300,000 per audit; typical ePA compliance overhead: 10–20 hours/month (€1,200–€2,400/month) for audit trail reconciliation
  • Frequency: Monthly (audit cycles); Risk: Quarterly Finanzamt spot-checks
  • Root Cause: Lack of integrated ePA middleware; manual consent/access logging creates audit gaps; paper + digital system fragmentation.

Why This Matters

This pain point represents a significant opportunity for B2B solutions targeting Retail Pharmacies.

Affected Stakeholders

Pharmacist, Pharmacy Assistant, Compliance Officer, Data Protection Officer

Deep Analysis (Premium)

Financial Impact

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Current Workarounds

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Get Solutions for This Problem

Full report with actionable solutions

$99$39
  • Solutions for this specific pain
  • Solutions for all 15 industry pains
  • Where to find first clients
  • Pricing & launch costs
Get Solutions Report

Methodology & Sources

Data collected via OSINT from regulatory filings, industry audits, and verified case studies.

Evidence Sources:

Related Business Risks

Request Deep Analysis

🇩🇪 Be first to access this market's intelligence